Analysis of Pharmaceuticals in Wastewater and Removal Using a Membrane Bioreactor

* NCBI

* Skip to main content

* Skip to navigation

* Resources

* How To

* About NCBI Accesskeys

My NCBISign in to NCBISign Out

PMC

US National Library of Medicine

National Institutes of Health

-------------------------------------------------

Top of Form

Search term Search database

Search

* Limits

* Advanced

* Journal list

* Help

Bottom of Form

* Journal List

* Springer Open Choice

* PMC1805043

Analytical and Bioanalytical Chemistry

Anal Bioanal Chem. 2007 February; 387(4): 1365–1377.

Published online 2006 November 18. doi:  10.1007/s00216-006-0883-6

PMCID: PMC1805043

Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor

Jelena Radjenovic,1 Mira Petrovic,1,2 and Damiá Barceló1

1Department of Environmental Chemistry, IIQAB-CSIC, C/Jordi Girona 18-26, 08034 Barcelona, Spain

2Institucio Catalana de Reserca i Estudis Avanzats (ICREA), 08010 Barcelona, Spain

Mira Petrovic, Email: mpeqam@cid.csic.es .

Corresponding author.

Author information ► Article notes ► Copyright and License information ►

Received July 6, 2006; Revised September 22, 2006; Accepted September 25, 2006.

Copyright © Springer-Verlag 2006

This article has been cited by other articles in PMC.

Go to:

-------------------------------------------------

Abstract

Much attention has recently been devoted to the life and behaviour of pharmaceuticals in the water cycle. In this study the behaviour of several pharmaceutical products in different therapeutic categories (analgesics and anti-inflammatory drugs, lipid regulators, antibiotics, etc.) was monitored during treatment of wastewater in a laboratory-scale membrane bioreactor (MBR). The results were compared with removal in a conventional activated-sludge (CAS) process in a wastewater-treatment facility. The performance of an MBR was monitored for approximately two months to investigate the long-term operational stability of the system and...